Drug
hepalatide
hepalatide is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
50%
Ph phase_1
3
50%
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
3(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(4)
Terminated(1)
Detailed Status
Completed4
Withdrawn1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (50.0%)
Phase 23 (50.0%)
Trials by Status
withdrawn117%
active_not_recruiting117%
completed467%
Recent Activity
1 active trials
Showing 5 of 6
active_not_recruitingphase_2
A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D
NCT06505928
completedphase_2
A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients
NCT05244057
completedphase_2
Study of Hepalatide in Chronic Hepatitis D(CHD) Patients
NCT05827146
withdrawnphase_1
A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin
NCT04662164
completedphase_1
Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers
NCT02612506
Clinical Trials (6)
Showing 6 of 6 trials
NCT06505928Phase 2
A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D
NCT05244057Phase 2
A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients
NCT05827146Phase 2
Study of Hepalatide in Chronic Hepatitis D(CHD) Patients
NCT04662164Phase 1
A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin
NCT02612506Phase 1
Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers
NCT03023787Phase 1
Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6